We are live on ! Find out more
WRF

Waddell & Reed Financial Portfolio holdings

AUM $48.6B
1-Year Est. Return 84.78%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+84.78%
3 Year Est. Return
+132.84%
5 Year Est. Return
+281.73%
10 Year Est. Return
–
AUM
$48.3B
AUM Growth
+$861M
Cap. Flow
-$1.97B
Cap. Flow %
-4.08%
Top 10 Hldgs %
16.97%
Holding
653
New
70
Increased
189
Reduced
256
Closed
63

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$270M
2
ADI icon
Analog Devices
ADI
+$214M
3
BABA icon
Alibaba
BABA
+$192M
4
CME icon
CME Group
CME
+$189M
5
QCOM icon
Qualcomm
QCOM
+$131M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$198M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$185M
3
ELV icon
Elevance Health
ELV
+$180M
4
BUD icon
AB InBev
BUD
+$151M
5
CELG
Celgene Corp
CELG
+$147M

Sector Composition

Rank Sector Weight
1 Technology 22.1%
2 Healthcare 15.74%
3 Consumer Discretionary 10.39%
4 Financials 9.26%
5 Industrials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMT icon
26
American Tower
AMT
$80.4B
$389M 0.81%
3,433,420
-497,032
-13% -$56.8M
AZPN
27
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$383M 0.79%
8,191,990
-1,837,400
-18% -$86M
XEC
28
DELISTED
CIMAREX ENERGY CO
XEC
$376M 0.78%
2,795,406
-395,671
-12% -$49.6M
SLB icon
29
SLB Ltd
SLB
$75B
$372M 0.77%
4,734,092
-316,962
-6% -$25.2M
BFH icon
30
Bread Financial
BFH
$4.38B
$369M 0.76%
2,157,151
-207,924
-9% -$35.4M
MJN
31
DELISTED
Mead Johnson Nutrition Company
MJN
$365M 0.75%
4,614,897
+340,803
+8% +$29.1M
VRTX icon
32
Vertex Pharmaceuticals
VRTX
$126B
$352M 0.73%
4,041,848
-216,630
-5% -$20.5M
EEFT icon
33
Euronet Worldwide
EEFT
$2.7B
$352M 0.73%
4,300,678
-563,936
-12% -$43.2M
AAPL icon
34
Apple
AAPL
$4.57T
$350M 0.72%
12,387,968
+2,171,308
+21% +$57.5M
MSCC
35
DELISTED
Microsemi Corp
MSCC
$337M 0.7%
8,036,660
-1,024,500
-11% -$39.2M
CP icon
36
Canadian Pacific Kansas City
CP
$80.5B
$329M 0.68%
10,775,210
-1,470,610
-12% -$43.2M
WNS
37
DELISTED
WNS Holdings
WNS
$317M 0.66%
10,584,188
-206,300
-2% -$5.94M
CERN
38
DELISTED
Cerner Corp
CERN
$305M 0.63%
4,934,400
-436,000
-8% -$27.5M
AIG icon
39
American International
AIG
$41.3B
$304M 0.63%
5,118,641
+580,511
+13% +$33.2M
HCA icon
40
HCA Healthcare
HCA
$89.5B
$302M 0.63%
3,996,582
-1,407,594
-26% -$108M
ALXN
41
DELISTED
Alexion Pharmaceuticals
ALXN
$302M 0.63%
2,464,979
+49,873
+2% +$6.42M
NBL
42
DELISTED
Noble Energy, Inc.
NBL
$301M 0.62%
8,430,564
-508,137
-6% -$17.8M
LRCX icon
43
Lam Research
LRCX
$390B
$291M 0.6%
30,738,990
-4,890,180
-14% -$44.5M
LMT icon
44
Lockheed Martin
LMT
$136B
$286M 0.59%
1,193,471
-17,830
-1% -$4.46M
ACIW icon
45
ACI Worldwide
ACIW
$5.42B
$284M 0.59%
14,640,964
-463,300
-3% -$8.79M
BMY icon
46
Bristol-Myers Squibb
BMY
$132B
$280M 0.58%
5,184,039
-3,089,832
-37% -$198M
EW icon
47
Edwards Lifesciences
EW
$51.7B
$272M 0.56%
6,763,374
+3,291,240
+95% +$124M
JCI icon
48
Johnson Controls International
JCI
$92.2B
$271M 0.56%
+5,814,818
New +$270M
NWL icon
49
Newell Brands
NWL
$2.56B
$260M 0.54%
4,943,909
+1,572,008
+47% +$81.3M
CTRA
50
DELISTED
Coterra Energy
CTRA
$259M 0.54%
10,032,319
+1,047,635
+12% +$26.2M
1
2
3 4 5

Similar funds

SHP
Spruce House Partnership New York $3.49B AUM
SBSB
Sullivan, Bruyette, Speros & Blaney Mclean, Virginia $2.27B AUM 50.71% 1-Year Est. Return
PAG
Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return
BUB
BBVA USA Bancshares Houston, Texas $2.1B AUM 62.57% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
PPCM
Pillar Pacific Capital Management Pacifica, California $1.29B AUM 80.18% 1-Year Est. Return
AAM
Anglepoint Asset Management George Town, Cayman Islands $1.28B AUM 131.9% 1-Year Est. Return
ALSV
ATP Life Science Ventures New York $898M AUM 84.86% 1-Year Est. Return

Waddell & Reed Financial's Q3 2016 Portfolio in Review

As of Q3 2016, Waddell & Reed Financial held 653 positions worth $48.3B, up 1.8% from $47.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Waddell & Reed Financial withdrew a net $1.97B in Q3 2016, closing 63 positions and reducing 256 holdings. Its most notable exit was PRA Health Sciences, Inc., an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Waddell & Reed Financial opened a new position in Johnson Controls International worth $271M.

  • Waddell & Reed Financial's largest Q3 2016 buy was Johnson Controls International: 5,814,818 shares worth $271M.
  • Waddell & Reed Financial added most to Alibaba in Q3 2016, an estimated $192M increase.
  • Waddell & Reed Financial's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $198M.
  • Waddell & Reed Financial fully exited PRA Health Sciences, Inc. in Q3 2016, selling an estimated $128M.
  • Waddell & Reed Financial's ten largest holdings make up 17% of its $48.3B portfolio in Q3 2016.
  • Waddell & Reed Financial opened 70 new positions and closed 63 in Q3 2016.
  • Waddell & Reed Financial's portfolio value rose 1.8% quarter-over-quarter to $48.3B.

Based on Waddell & Reed Financial's 13F filing for Q3 2016, filed 14 Nov 2016.